Organoid-on-Chip Platforms as Predictive Models of Human Disease: Promise and Pitfalls
Integrative Biomedical Research · 01.04.2026 · 10 (1) · 1-8
DOI: 10.25163/biomedical.10110881 ↗Kurz gefasst
Fachartikel in der Zeitschrift Integrative Biomedical Research, online erschienen am 01.04.2026.
Abstract (Originalsprache)
Drug development still runs into what many in the field have come to call the preclinical valley of death — the uncomfortable reality that close to 90% of candidates clearing animal and two-dimensional (2D) testing nevertheless fail once they reach human trials. Static three-dimensional (3D) organoids narrowed, but did not close, this gap, remaining bounded by passive-diffusion limits, immature phenotypes, and considerable batch-to-batch variability. We performed a structured narrative synthesis of peer-reviewed literature, retrieved information following a reproducible search-and-screening protocol, to characterize the biological principles, microengineering strategies, disease-modeling applications, and artificial intelligence (AI) integration of organoid-on-chip (OoC) platforms. Convective perfusion, physiologically tuned fluid shear stress, cyclic strain, and tunable viscoelastic hydrogels emerged as central, organ-specific drivers of structural and functional maturation across brain, kidney, liver, gut, cardiac, and tumor chips. AI and machine-learning pipelines — from convolutional neural networks for segmentation to deep reinforcement learning for closed-loop homeostasis — now support scalable, increasingly reproducible operation, and patient-derived organoid trials are beginning to inform regulatory and clinical decisions. Organoid-on-chip platforms constitute a biologically grounded, increasingly AI-augmented alternative to conventional preclinical models. Full clinical and industrial integration, however, will depend on resolving vascularization deficits, polydimethylsiloxane (PDMS) drug adsorption, standardization gaps, and cost barriers.
Zitieren
APA
(2026). Organoid-on-Chip Platforms as Predictive Models of Human Disease: Promise and Pitfalls. Integrative Biomedical Research, 10(1), 1-8. https://doi.org/10.25163/biomedical.10110881
Vancouver
Organoid-on-Chip Platforms as Predictive Models of Human Disease: Promise and Pitfalls. Integrative Biomedical Research. 2026;10(1):1-8. doi:10.25163/biomedical.10110881
BibTeX
@article{euvimed2026,
title = {Organoid-on-Chip Platforms as Predictive Models of Human Disease: Promise and Pitfalls},
journal = {Integrative Biomedical Research},
year = {2026},
volume = {10},
number = {1},
pages = {1--8},
doi = {10.25163/biomedical.10110881}
}
EUVIMED